Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.2640 EUR
519.84 M EUR
9.64 B EUR
219.90 M
About GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED
Sector
CEO
Hong Li
Headquarters
Guangzhou
Website
Founded
1997
ISIN
CNE100000387
FIGI
BBG000BGZ093
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. engages in the manufacture, wholesale, retail, import, and export of pharmaceutical products, medical apparatus, and Chinese medicine. It operates in the following segments: Great Southern Traditional Chinese Medicine (TCM), Great Health, Great Commerce, and Other. The Great Southern TCM segment provides research, development, manufacturing, and sales for Chinese and Western medicine. The Great Health segment refers to the research, development, manufacturing, and sales for the products of Great Health. The Great Commerce segment relates to the wholesale, retail, import, and export for Western medicine, Chinese medicine, and medical apparatus and instruments. The Other segment is involved in other manufacturing and distributing traditional Chinese medicines activities. The company was founded on September 1, 1997 and is headquartered in Guangzhou, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. stocks are traded under the ticker GU5.
We've gathered analysts' opinions on Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. future price: according to them, GU5 price has a max estimate of 3.09 EUR and a min estimate of 2.01 EUR. Watch GU5 chart and read a more detailed Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. stock forecast: see what analysts think of Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. and suggest that you do with its stocks.
Yes, you can track Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. financials in yearly and quarterly reports right on TradingView.
Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. is going to release the next earnings report on Mar 17, 2025. Keep track of upcoming events with our Earnings Calendar.
GU5 earnings for the last quarter are 0.06 EUR per share, whereas the estimation was 0.06 EUR resulting in a 0.00% surprise. The estimated earnings for the next quarter are 0.04 EUR per share. See more details about Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. earnings.
GU5 net income for the last quarter is 76.60 M EUR, while the quarter before that showed 76.31 M EUR of net income which accounts for 0.37% change. Track more Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. financial stats to get the full picture.
Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. dividend yield was 3.78% in 2023, and payout ratio reached 29.85%. The year before the numbers were 3.53% and 28.64% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 15, 2024, the company has 28.05 K employees. See our rating of the largest employees — is Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. on this list?
Like other stocks, GU5 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. stock right from TradingView charts — choose your broker and connect to your account.